通过临床试验共享资源招募非裔美国人参与国家肿瘤学临床试验。
Recruitment of African Americans to National Oncology Clinical Trials through a clinical trial shared resource.
作者信息
Wujcik Debra, Wolff Steven N
机构信息
Meharry Medical College, Nashville, TN 37208, USA.
出版信息
J Health Care Poor Underserved. 2010 Feb;21(1 Suppl):38-50. doi: 10.1353/hpu.0.0251.
Abstract
In 2000, using National Institutes of Health/National Cancer Institute (NIH/NCI) U54 funds, a clinical trials shared resource was established at Nashville General Hospital at Meharry to attract more African Americans to national cancer clinical trials. This Report from the Field describes the model used to achieve this end.
摘要
2000年，利用美国国立卫生研究院/国立癌症研究所（NIH/NCI）的U54基金，梅哈里纳什维尔综合医院建立了一个临床试验共享资源库，以吸引更多非裔美国人参与全国性癌症临床试验。本实地报告介绍了实现这一目标所采用的模式。
相似文献
1
Recruitment of African Americans to National Oncology Clinical Trials through a clinical trial shared resource.通过临床试验共享资源招募非裔美国人参与国家肿瘤学临床试验。
J Health Care Poor Underserved. 2010 Feb;21(1 Suppl):38-50. doi: 10.1353/hpu.0.0251.
2
Novel method for benchmarking recruitment of African American cancer patients to clinical therapeutic trials.评估非裔美国癌症患者参与临床治疗试验招募情况的新方法。
J Clin Oncol. 2008 Nov 1;26(31):5074-7. doi: 10.1200/JCO.2008.17.3039. Epub 2008 Sep 22.
3
Increasing diversity in clinical trials: demographic trends at the National Cancer Institute, 2005-2020.临床试验中的多样性增加：2005 年至 2020 年美国国家癌症研究所的人口趋势。
J Natl Cancer Inst. 2024 Jul 1;116(7):1063-1071. doi: 10.1093/jnci/djae018.
4
Patterns of National Cancer Institute-Sponsored Clinical Trial Enrollment in Black Adolescents and Young Adults.国家癌症研究所资助的临床试验中黑人青少年和年轻成年人的入组模式。
Cancer Med. 2021 Nov;10(21):7620-7628. doi: 10.1002/cam4.4292. Epub 2021 Sep 30.
5
Representation of African-Americans, Hispanics, and whites in National Cancer Institute cancer treatment trials.非裔美国人、西班牙裔和白人在国立癌症研究所癌症治疗试验中的代表性。
J Natl Cancer Inst. 1996 Jun 19;88(12):812-6. doi: 10.1093/jnci/88.12.812.
6
Creating a "culture of research" in a community hospital: Strategies and tools from the National Cancer Institute Community Cancer Centers Program.在社区医院营造“研究文化”：来自美国国立癌症研究所社区癌症中心项目的策略与工具
Clin Trials. 2015 Jun;12(3):246-56. doi: 10.1177/1740774515571141. Epub 2015 Feb 17.
7
Representation of Asian Americans in clinical cancer trials.亚裔美国人在临床癌症试验中的代表性。
Ann Epidemiol. 2000 Nov;10(8 Suppl):S61-67. doi: 10.1016/s1047-2797(00)00198-8.
8
Charting the future of cancer health disparities research: A position statement from the American Association for Cancer Research, the American Cancer Society, the American Society of Clinical Oncology, and the National Cancer Institute.绘制癌症健康差异研究的未来蓝图：美国癌症研究协会、美国癌症协会、美国临床肿瘤学会及美国国立癌症研究所的立场声明。
CA Cancer J Clin. 2017 Sep;67(5):353-361. doi: 10.3322/caac.21404. Epub 2017 Jul 24.
9
Race versus place of service in mortality among medicare beneficiaries with cancer.医疗保险受益人群癌症死亡率的种族差异与服务地点差异。
Cancer. 2010 Jun 1;116(11):2698-706. doi: 10.1002/cncr.25097.
10
REACH-Meharry community-campus partnership: developing culturally competent health care providers.REACH-梅哈里社区与校园合作关系：培养具备文化能力的医疗保健提供者。
J Health Care Poor Underserved. 2006 May;17(2 Suppl):78-87. doi: 10.1353/hpu.2006.0085.
引用本文的文献
1
Closing the gap: proposing a socio-ecological framework to make cancer clinical trials more accessible, equitable, and acceptable to adolescents and young adults.缩小差距：提出一个社会生态框架，使癌症临床试验对青少年和青年更易获得、更公平且更可接受。
Oncologist. 2024 Nov 4;29(11):918-921. doi: 10.1093/oncolo/oyae257.
2
Patiromer to Reduce Albuminuria Through Increased Renin Angiotensin Aldosterone System Inhibition in Patients With CKD-A Feasibility Trial.帕替罗姆通过增强肾素-血管紧张素-醛固酮系统抑制作用降低慢性肾脏病患者蛋白尿的可行性试验
Kidney Int Rep. 2024 May 14;9(8):2399-2409. doi: 10.1016/j.ekir.2024.05.006. eCollection 2024 Aug.
3
Strategies for increasing accrual in cancer clinical trials: What is the evidence?增加癌症临床试验入组率的策略：有哪些证据？
Cancer Med. 2024 May;13(10):e7298. doi: 10.1002/cam4.7298.
4
"Lord Knows What's Being Done with My Blood!": Black Women's Perceptions of Biospecimen Donation for Clinical Research in the United States.“天知道我的血液被拿去做什么了！”：美国黑人女性对临床研究生物样本捐赠的看法
J Racial Ethn Health Disparities. 2025 Jun;12(3):1856-1865. doi: 10.1007/s40615-024-02015-y. Epub 2024 May 7.
5
Enhancing Recruitment and Retention of Minority Populations for Clinical Research in Pulmonary, Critical Care, and Sleep Medicine: An Official American Thoracic Society Research Statement.提高肺脏、危重症和睡眠医学临床研究中少数民族人群的招募和保留率：美国胸科学会官方研究声明。
Am J Respir Crit Care Med. 2021 Aug 1;204(3):e26-e50. doi: 10.1164/rccm.202105-1210ST.
6
Overcoming Barriers to Clinical Trial Participation: Outcomes of a National Clinical Trial Matching and Navigation Service for Patients With a Blood Cancer.克服临床试验参与障碍：为血液癌症患者提供全国临床试验匹配和导航服务的结果。
JCO Oncol Pract. 2021 Dec;17(12):e1866-e1878. doi: 10.1200/OP.20.01068. Epub 2021 Jun 2.
7
Systematic review of barriers and facilitators to clinical trial enrollment among adolescents and young adults with cancer: Identifying opportunities for intervention.系统评价青少年和青年癌症患者参与临床试验的障碍和促进因素：确定干预机会。
Cancer. 2020 Mar 1;126(5):949-957. doi: 10.1002/cncr.32675. Epub 2019 Dec 23.
8
Barriers to accrual and enrollment in brain tumor trials.脑肿瘤试验入组和纳入的障碍。
Neuro Oncol. 2019 Sep 6;21(9):1100-1117. doi: 10.1093/neuonc/noz104.
9
Systematic Review and Meta-Analysis of the Magnitude of Structural, Clinical, and Physician and Patient Barriers to Cancer Clinical Trial Participation.系统评价和荟萃分析癌症临床试验参与的结构、临床以及医生和患者障碍的程度。
J Natl Cancer Inst. 2019 Mar 1;111(3):245-255. doi: 10.1093/jnci/djy221.
10
Strategies for recruitment and retention of underrepresented populations with chronic obstructive pulmonary disease for a clinical trial.招募和保留慢性阻塞性肺疾病代表性不足人群参与临床试验的策略。
BMC Med Res Methodol. 2019 Feb 21;19(1):39. doi: 10.1186/s12874-019-0679-y.
本文引用的文献
1
African American women who receive primary anthracycline- and taxane-based chemotherapy for triple-negative breast cancer suffer worse outcomes compared with white women.与白人女性相比，接受以蒽环类药物和紫杉烷类药物为主的一线化疗的非裔美国三阴乳腺癌女性患者的预后更差。
J Clin Oncol. 2009 Aug 1;27(22):e35-7; author reply e38-9. doi: 10.1200/JCO.2008.21.5509. Epub 2009 Jun 29.
2
Factors associated with patient navigators' time spent on reducing barriers to cancer treatment.与患者导航员在减少癌症治疗障碍方面所花费时间相关的因素。
J Natl Med Assoc. 2008 Nov;100(11):1290-7. doi: 10.1016/s0027-9684(15)31507-8.
3
Timing is everything: methodologic issues locating and recruiting medically underserved women for abnormal mammography follow-up research.时机至关重要：为异常乳房X光检查后续研究寻找和招募医疗服务不足女性的方法学问题。
Contemp Clin Trials. 2008 Jul;29(4):537-46. doi: 10.1016/j.cct.2008.01.003. Epub 2008 Jan 17.
4
Challenges and strategies in recruitment of ethnically diverse populations for cancer nursing research.癌症护理研究中招募不同种族人群面临的挑战与策略
Oncol Nurs Forum. 2007 Nov;34(6):1187-94. doi: 10.1188/07.ONF.1187-1194.
5
Attitudes toward participation in breast cancer randomized clinical trials in the African American community: a focus group study.非裔美国人社区对参与乳腺癌随机临床试验的态度：一项焦点小组研究。
Cancer Nurs. 2007 Jul-Aug;30(4):261-9. doi: 10.1097/01.NCC.0000281732.02738.31.
6
Attitudes of African American and low socioeconomic status white women toward medical research.非裔美国女性和社会经济地位较低的白人女性对医学研究的态度。
J Health Care Poor Underserved. 2007 Feb;18(1):85-99. doi: 10.1353/hpu.2007.0008.
7
Provider roles in the recruitment of underrepresented populations to cancer clinical trials.医疗服务提供者在招募代表性不足人群参与癌症临床试验中的角色。
Cancer. 2007 Feb 1;109(3):465-76. doi: 10.1002/cncr.22436.
8
The influence of race on the attitudes of radiation oncology patients towards clinical trial enrollment.种族对放射肿瘤学患者参与临床试验态度的影响。
Am J Clin Oncol. 2006 Dec;29(6):593-9. doi: 10.1097/01.coc.0000236213.61427.84.
9
Investigator beliefs and reported success in recruiting minority participants.研究者的信念以及在招募少数族裔参与者方面所报告的成功率。
Contemp Clin Trials. 2006 Dec;27(6):580-6. doi: 10.1016/j.cct.2006.05.006. Epub 2006 Jul 12.
10
Efforts to locate low-income women for a study on mammography rescreening: implications for public health practice.为一项关于乳房X光复查的研究寻找低收入女性的努力：对公共卫生实践的启示。
J Community Health. 2006 Jun;31(3):249-61. doi: 10.1007/s10900-005-9006-0.
Zotero 插件